Vicadrostat by Boehringer Ingelheim International for Chronic Kidney Disease (Chronic Renal Failure): Likelihood of Approval

Vicadrostat is under clinical development by Boehringer Ingelheim International and currently in Phase III for Chronic Kidney Disease (Chronic Renal Failure).

World’s first deaths from Oropouche fever recorded in Brazil

The world’s first deaths have been recorded from Oropouche fever, caused by a mosquito-borne virus that has spread silently from the Brazilian Amazon rainforest, raising

August 2, 2024

Pilot Awards for Global Brain Health Leaders awarded to encourage innovative dementia research

Today, the Alzheimer’s Association, Global Brain Health Institute (GBHI), and the UK-based Alzheimer’s Society announced the most recent awardees of the Pilot Awards for Global

October 31, 2023

What natural compounds can help you manage your rosacea?

Researchers reviewed existing data on rosacea management using botanicals.

February 7, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.